Westchester Capital Management (New York)’s Eli Lilly LLY Stock Holding History

Westchester Capital Management (New York)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-117,900	Closed	-$9.12M	–	110
2018 Q1	$9.12M	Buy	+117,900	New	+$9.49M	0.35%	37
2014 Q2	–	Sell	-252,800	Closed	-$14.9M	–	163
2014 Q1	$14.9M	Buy	252,800 +12,400	+5%	+$692K	0.19%	101
2013 Q4	$12.3M	Buy	240,400 +100	+0%	+$5.01K	0.18%	103
2013 Q3	$12.1M	Sell	240,300 -661,100	-73%	-$34.6M	0.22%	89
2013 Q2	$44.3M	Buy	+901,400	New	+$49M	0.82%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Westchester Capital Management (New York)'s LLY Position: Q2 2014 in Review

Westchester Capital Management (New York) sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 263,700 shares — an estimated $15.5M sold.

Westchester Capital Management (New York) first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $44.3M in Q2 2013. 1,029 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

Westchester Capital Management (New York) reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
Westchester Capital Management (New York) sold 263,700 Eli Lilly shares in Q2 2014, an estimated $15.5M.
Westchester Capital Management (New York) first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
Westchester Capital Management (New York)'s Eli Lilly position peaked at $44.3M in Q2 2013.
1,029 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2014, filed 14 Aug 2014.